The post Here’s How Ethereum Created History Today Amid Price Breakout appeared on BitcoinEthereumNews.com. Ethereum has entered a pivotal phase after breaking The post Here’s How Ethereum Created History Today Amid Price Breakout appeared on BitcoinEthereumNews.com. Ethereum has entered a pivotal phase after breaking

Here’s How Ethereum Created History Today Amid Price Breakout

Ethereum has entered a pivotal phase after breaking out of a bullish pattern that constrained price action for nearly two months. ETH pushed decisively above a key resistance zone, confirming renewed upside momentum. 

This technical breakout coincided with a historic surge in network participation, marking a significant moment for Ethereum’s recovery narrative.

Sponsored

Sponsored

Ethereum Breaks 7 Year Record

Ethereum recorded an unprecedented 447,000 new investors onboarding within a single 24-hour period. New addresses represent wallets interacting with ETH for the first time. This milestone reflects a sharp acceleration from recent trends, where daily new addresses had already surpassed 300,000 during the past week.

The steady rise in first-time participants throughout the last month highlights expanding organic demand. More than 300,000 new addresses have been transacting daily, and the latest spike marked the end of a 7-year record of 351,000. This influx typically aligns with improving price structure, reinforcing Ethereum’s breakout, and supporting sustained recovery.

Want more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.

Ethereum New Addresses. Source: Glassnode

Rising address growth also suggests broader adoption beyond speculative trading. Increased participation strengthens network utility, which historically supports price stability during rallies. As fresh capital enters the ecosystem, Ethereum gains resilience against short-term volatility.

Sponsored

Sponsored

Why Are Young ETH Holders Unlikely To Sell?

From a macro perspective, the Short-Term Holder Net Unrealized Profit and Loss metric is beginning to trend higher. This indicator tracks profitability among recent buyers and offers insight into selling pressure. While STH NUPL is rising, it remains firmly within the capitulation zone.

This positioning is constructive for price continuation. Average short-term Ethereum holders are still underwater, reducing incentives to sell into strength. As long as losses persist, most STHs are likely to hold positions, limiting distribution during the early stages of a rally.

Ethereum NUPL. Source: Glassnode

Historically, Ethereum rallies gain traction while STH NUPL remains negative but improving. Once the metric exits capitulation and turns positive, selling pressure often increases. Until that shift occurs, ETH retains room to climb without facing aggressive profit-taking.

ETH Price Breaks Out

Ethereum trades near $3,317 at the time of writing, holding firmly above the $3,287 support level. This zone marked the upper boundary of the triangle pattern that ETH escaped in the past 24 hours. The breakout projects a potential 29.4% upside move, targeting approximately $4,240.

Strengthening fundamentals supports this outlook. Rising address growth and restrained selling suggest fresh capital is driving momentum. A sustained move above $3,441 would reinforce the breakout. Clearing that level could carry ETH toward $3,607, confirming trend continuation and improving medium-term confidence.

ETH Price Analysis. Source: TradingView

However, downside risk remains if sentiment shifts abruptly. Should short-term holders sell prematurely to offset losses, Ethereum could slip back below $3,287. A return inside the triangle would weaken the bullish structure. In that case, ETH could retrace toward $3,131 or $3,000, invalidating the breakout thesis.

Source: https://beincrypto.com/ethereum-forms-history-as-price-breaks-out/

Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$3,290.9
$3,290.9$3,290.9
-1.22%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23